SYK · Stryker Corp · Investor Relations
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-11-09 | Stryker announces intention to nominate Jim Davis to board of directors |
| 2026-10-29 | Stryker reports third quarter 2026 operating results |
| 2026-10-27 | Stryker to participate in the 2026 Jefferies Global Healthcare Conference |
| 2026-10-26 | Stryker completes acquisition of ZuriMED to enhance its shoulder offering |
| 2026-10-12 | Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery |
| 2026-10-06 | Stryker announces leadership succession |
| 2026-10-01 | Stryker to announce third quarter 2026 financial results |
| 2026-09-04 | Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference |
| 2026-08-31 | Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering |
| 2026-08-27 | Stryker to participate in the 2026 Wells Fargo Healthcare Conference |
| 2026-08-05 | Stryker declares an $0.88 per share quarterly dividend |
| 2026-07-30 |
Stryker reports second quarter 2026 operating results
Portage, Michigan, July 30, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the second quarter of 2026: Second Quarter Results Reported net sales increased 9.4% to $6.6 billion Organic net sales increased 9.0% Reported operating income margin of 25.2% Adjusted operating income margin (1) increased 170 bps to 27.4% Reported EPS increased 44.1% to $3.30 Adjusted EPS (1) increased 17.9% to $3.69 Second Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 9.7 % 0.5 % 9.2 % |
| 2026-07-01 | Stryker to announce second quarter 2026 financial results |
| 2026-05-07 | Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio |
| 2026-05-07 | Stryker declares an $0.88 per share quarterly dividend |
| 2026-05-01 | Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference |
| 2026-04-30 |
Stryker reports first quarter 2026 operating results
Portage, Michigan, April 30, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the first quarter of 2026: First Quarter Results Reported net sales increased 2.6% to $6.0 billion Organic net sales increased 2.4% Reported operating income margin of 15.5% Adjusted operating income margin (1) contracted 180 bps to 21.1% Reported EPS increased 14.2% to $1.93 Adjusted EPS (1) decreased 8.5% to $2.60 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 5.0 % 1.4 % 3.6 % |
| 2026-04-13 | Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio |
| 2026-04-01 | Stryker to announce financial results for its first quarter of fiscal year 2026 |
| 2026-03-31 | Stryker names Nick Mead Vice President, Investor Relations |
| 2026-03-23 | Stryker announces Annual Meeting of Shareholders |
| 2026-02-04 | Stryker declares an $0.88 per share quarterly dividend |
| 2026-01-29 |
Stryker reports 2025 operating results and 2026 outlook
Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Fourth Quarter Results Reported net sales increased 11.4% to $7.2 billion Organic net sales increased 11.0% Reported operating income margin of 25.2% Adjusted operating income margin (1) increased 100 bps to 30.2% Reported EPS increased 56.0% to $2.20 Adjusted EPS (1) increased 11.5% to $4.47 Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures Organic MedSurg and Neurotechnology 17.5 % 0.9 % 16.6 % |
| 2026-01-05 |
Stryker to announce financial results for its fourth quarter and full year 2025
Portage, Michigan, Jan. 05, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK) announced that it will report financial results for its fourth quarter and full year 2025 on Thursday, January 29, 2026. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s fourth quarter and full year that ended December 31, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, January 29, 2026, to discuss its fourth quarter and full year 2025 results. The webcast can be accessed at Stryker - Events & Presentations . An archive of the webcast will also be available on the company's website two hours after the live call ends. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help |